EBOS Group Limited

EBOS Group Limited

Hinterlegungsschein · US2787271020 (OTC)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu EBOS Group Limited
Kein Kurs
Schlusskurs OTC 28.04.2026: 26,42 USD
28.04.2026 20:00
Aktuelle Kurse von EBOS Group Limited
BörseTickerWährungLetzter UmsatzKursTagesveränderung
OTC: UTC
UTC
EBOSY
USD
28.04.2026 20:00
26,42 USD
0,00 USD
Firmenprofil zu EBOS Group Limited Hinterlegungsschein
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Unternehmensdaten

Name EBOS Group Limited
Firma EBOS Group Limited
Website https://www.ebosgroup.com
Heimatbörse OTC UTC
ISIN US2787271020
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Medical - Specialties
CEO Adam Luke Hall BCOMM, LLB (HONS),
Marktkapitalisierung 1 Mrd.
Land Australien
Währung USD
Mitarbeiter 5,2 T
Adresse 737 Bourke Street, 3008 Docklands
IPO Datum 2017-05-11
Dividenden von 'EBOS Group Limited'
Ex-Datum Dividende pro Aktie
09.03.2026 1,70 USD
08.09.2025 0,75 USD
03.03.2025 0,68 USD
03.09.2024 0,79 USD
02.03.2023 0,69 USD
08.09.2022 0,62 USD
03.03.2022 0,67 USD
09.09.2021 0,68 USD
04.03.2021 0,64 USD
24.09.2020 0,55 USD

Ticker Symbole

Name Symbol
Over The Counter EBOSY
Weitere Aktien
Investoren, die EBOS Group Limited halten, haben auch folgende Aktien im Depot:
DZ BANK IS.A1411 VAR
DZ BANK IS.A1411 VAR Anleihe
ORICO INC
ORICO INC Aktie